Open AccessNewborn Dried Blood Spots for Serologic Surveys of COVID-19
Author(s) -
Feimei Liu,
Mytien Nguyen,
Pavithra Vijayakumar,
Alanna R. Kaplan,
Amit Meir,
Yile Dai,
Eric Y. Wang,
Hannah Walsh,
Aaron M. Ring,
Saad B. Omer,
Shelli Farhadian
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002918
Subject(s) - dried blood , serology , covid-19 , dried blood spot , population , medicine , virology , pediatrics , antibody , immunology , environmental health , biology , outbreak , disease , infectious disease (medical specialty) , chemistry , chromatography , genetics
There is an urgent need for inexpensive, population-wide surveillance testing for COVID-19. We tested newborn dried blood spot (DBS) anti-SARS-CoV-2 antibodies for all infants born at Yale from March to May 2020, and found that newborn DBS serologies reflect maternal and population-wide infection rates during the study period. This suggests a role for DBS in COVID-19 surveillance in areas where viral testing is limited.